Pharmananogene Research Group

• Otaegui D, Rodríguez-Gascón A, Zubia A, Cossio FP, Pedraz JL.  Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice Cancer Chemotherapy and Pharmacology,  2009;  64,  153 - 159
• del Pozo-Rodríguez A, Pujals S, Delgado D, Solinís MA, Gascón AR, Giralt E, Pedraz JL.  A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors Journal of Controlled Release,  2009;  133,  52 - 59
• del Pozo-Rodríguez A, Solinís MA, Gascón AR, Pedraz JL.  Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy European Journal of Pharmaceutics and Biopharmaceutics,  2009;  71,  181 - 189
• Canut A, Martín-Herrero JE, Maortua H, Labora A, Isla A, Gascón AR.  Impact of the pathogen shifts in acute otitis media on the clinical efficacy of several antibiotics: a therapeutic outcomes model Journal of Chemotherapy,  2009;  214,  408 - 413
• Zuñiga L, Calvo B.  Global vision about the biological medicinal products: biosimilars Current Pharmaceutical Biotechnology,  2009;  10,  772 - 774
• Zuñiga L, Calvo B.  Regulatory aspects of biosimilars in Europe Trends in Biotechnology,  2009;  27,  385 - 387